Bio-Techne Corporation
TECH
$72.25
-$0.06-0.08%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.22B | 1.21B | 1.22B | 1.22B | 1.22B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.22B | 1.21B | 1.22B | 1.22B | 1.22B |
| Cost of Revenue | 410.16M | 406.84M | 405.94M | 403.53M | 408.52M |
| Gross Profit | 804.88M | 803.97M | 809.63M | 813.20M | 811.12M |
| SG&A Expenses | 435.56M | 439.23M | 482.68M | 491.99M | 488.21M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 940.49M | 942.92M | 986.60M | 995.38M | 996.22M |
| Operating Income | 274.55M | 267.89M | 228.98M | 221.35M | 223.41M |
| Income Before Tax | 240.68M | 147.14M | 114.19M | 106.28M | 98.46M |
| Income Tax Expenses | 58.82M | 37.58M | 33.09M | 28.30M | 25.06M |
| Earnings from Continuing Operations | 181.86 | 109.56 | 81.10 | 77.99 | 73.40 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 181.86M | 109.56M | 81.10M | 77.99M | 73.40M |
| EBIT | 274.55M | 267.89M | 228.98M | 221.35M | 223.41M |
| EBITDA | 371.91M | 368.22M | 332.71M | 327.45M | 333.31M |
| EPS Basic | 1.17 | 0.70 | 0.52 | 0.50 | 0.46 |
| Normalized Basic EPS | 1.08 | 1.05 | 0.91 | 0.87 | 0.87 |
| EPS Diluted | 1.15 | 0.68 | 0.50 | 0.48 | 0.45 |
| Normalized Diluted EPS | 1.07 | 1.04 | 0.90 | 0.86 | 0.87 |
| Average Basic Shares Outstanding | 623.72M | 622.54M | 623.59M | 626.18M | 629.25M |
| Average Diluted Shares Outstanding | 627.79M | 626.52M | 628.06M | 631.69M | 636.44M |
| Dividend Per Share | 0.32 | 0.32 | 0.32 | 0.32 | 0.32 |
| Payout Ratio | 27.45% | 45.47% | 61.50% | 64.30% | 68.65% |